Eosinophilic Gastritis Clinical Trial
Official title:
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of AK002 in Patients With Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002), given monthly for 6 doses, in patients with moderately to severely active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) who have an inadequate response with, lost response to, or were intolerant to standard therapies
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03664960 -
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
|
Phase 2 | |
Recruiting |
NCT05831176 -
A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03678545 -
Dupilumab in Eosinophilic Gastritis
|
Phase 2 | |
Completed |
NCT03496571 -
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
|
Phase 2 | |
Recruiting |
NCT02523118 -
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
|
||
Recruiting |
NCT05229432 -
Study of Gastric Motility in Eosinophilic Gastritis
|
||
Withdrawn |
NCT01779154 -
Eosinophilic Gastrointestinal Disorders Patient Registry
|
N/A | |
Completed |
NCT05251909 -
Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
|
Phase 3 | |
Completed |
NCT04620811 -
An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
|
Phase 3 | |
Withdrawn |
NCT05152563 -
A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis
|
Phase 3 | |
Completed |
NCT02897271 -
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
|